Cargando…
Controlled in-cell activation of RNA therapeutics using bond-cleaving bio-orthogonal chemistry
Temporal control of siRNA activation is a major challenge for RNAi-based therapeutics. The majority of the reported siRNA delivery systems rely on environmental factors, such as differences in extracellular and intracellular redox potential, ATP concentration, or pH to activate an siRNA payload. How...
Autores principales: | Khan, Irfan, Seebald, Leah M., Robertson, Neil M., Yigit, Mehmet V., Royzen, Maksim |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Royal Society of Chemistry
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5621156/ https://www.ncbi.nlm.nih.gov/pubmed/28989610 http://dx.doi.org/10.1039/c7sc01380a |
Ejemplares similares
-
In Vivo Bioorthogonal Chemistry Enables Local Hydrogel
and Systemic Pro-Drug To Treat Soft Tissue Sarcoma
por: Mejia Oneto, Jose M., et al.
Publicado: (2016) -
Bio-Orthogonal Chemistry and Reloadable Biomaterial
Enable Local Activation of Antibiotic Prodrugs and Enhance Treatments
against Staphylococcus aureus Infections
por: Czuban, Magdalena, et al.
Publicado: (2018) -
Designed Artificial Protein Heterodimers With Coupled Functions Constructed Using Bio-Orthogonal Chemistry
por: Johnson, Rachel L., et al.
Publicado: (2021) -
Introduction to ‘Development of bio-orthogonal tools’
por: Zhang, Yan, et al.
Publicado: (2022) -
The third orthogonal dynamic covalent bond
por: Lascano, Santiago, et al.
Publicado: (2016)